PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
22639176-12	2013	Gene expression of iNOS was down-regulated by enalapril either alone or in combination with L-NAME.	Enalapril	46-55	nitric oxide synthase 2	Rattus norvegicus	19-23	
24941431-6	2014	RESULTS: Administration of the enalapril or the exenatide in diabetic rats resulted in a significant reduction both fibronectin, induced nitric oxide synthase (i-NOS) expression in glomerular area and urine protein levels.	Enalapril	31-40	nitric oxide synthase 2	Rattus norvegicus	160-165	
24941431-8	2014	CONCLUSION: The beneficial effects of enalapril and exenatide which reduces fibronectin, i-NOS expression and urine protein levels or increases recovery of glomerules, might be used for preventing the harmful effects of diabetic nephropathy.	Enalapril	38-47	nitric oxide synthase 2	Rattus norvegicus	89-94	
17902367-5	2007	Angiotensin-converting enzyme inhibitor (enalapril) administration (20 mg/kg, 30 or 55 days) up regalate constitutive NO synthesis by arginase, iNOS, nitrate reductase activity and ROS and peroxynitrite generation inhibition thus restore endothelium-dependent relaxations of VSM in aging rats.	Enalapril	41-50	nitric oxide synthase 2	Rattus norvegicus	144-148	
12381094-5	2002	The intensity of immunostaining for iNOS was increased approximately 1.9-fold compared with the control in the combined enarapril and L-arginine group as well as in the enalapril group.	Enalapril	169-178	nitric oxide synthase 2	Rattus norvegicus	36-40	
12381094-6	2002	These data suggest that the apoptosis in the neointima is different for L-arginine, losartan and enalapril under similar conditions and was higher under treatment with enalapril, not only via the action of NO or blocking of the AT1, but also by upregulation of iNOS.	Enalapril	168-177	nitric oxide synthase 2	Rattus norvegicus	261-265